Skip to content
Research Article Open access CC BY 4.0

Docking Simulation Analysis of Natural Ingredients as Anti Virus SARS-Cov-2 on Helicase Inhibitors

Nya Daniaty Malau, St. Fatimah Azahra

Asian Journal of Research in Computer Science · pp. 94–106 · Published 8 Nov 2022

10.9734/ajrcos/2022/v14i4294

Abstract

Aims: To find active compounds from natural ingredients that have the potential to be antivirals of SARS-CoV-2. Study Design: Simulation research. Place and Duration of Study: Physics Laboratory, Department of Physics Education, Universitas Kristen Indonesia, between December 2021 and August 2022. Methodology: The method used is a computational simulation commonly known as docking simulation or molecular docking. There are several steps taken, namely ligand and receptor preparation, docking simulation and analysis of simulation results. Results: The results obtained were from 22 ligand compounds of natural material selected as helicase receptor inhibitors, 14 ligand compounds were found that met the requirements according to Lipinski's five rules, namely Emodin, Luteolin, Curcumin, Kaemferol, Quercetin, Myricetin, Scutellarein, 10-Gingerol, Shogaol, Mangostin, Piseatanol, Diallyl disulfide, Cyperotundone and Eugenol. Of the 14 ligand compounds simulated with helicase receptors, it turned out that 14 stable ligand compounds were used as helicase receptor inhibitors. However, among the 14 ligands, myricetin is the most stable ligand with the smallest Gibbs free energy value, which is -8.7 kcal/mol. Conclusion: An active ingredient compound has been found that has the potential as an antivirus sars-COV-2 in the Helicase receptor, Myricetin from clove plants (Syzygium aromaticum). These results can be used as a basis for drug development for the development of SARS-COV-2 antivirus in the future.

SARS-CoV-2 docking ligand gibbs free energy drug

References (22)

  1. 1 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor [DOI]
  2. 2 A new coronavirus associated with human respiratory disease in China [DOI]
  3. 3 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [DOI]
  4. 4 Coronavirus envelope protein: current knowledge [DOI]
  5. 5 Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus [DOI]
  6. 6 Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction [DOI]
  7. 7 Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13 [DOI]
  8. 8 Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection—What can we learn from earlier mistakes? [DOI]
  9. 9 How Does Consensus Scoring Work for Virtual Library Screening? An Idealized Computer Experiment [DOI]
  10. 10 Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors [DOI]
  11. 11 Inhibition of SARS‐CoV 3C‐like Protease Activity by Theaflavin‐3,3′‐digallate (TF3) [DOI]
  12. 12 Natural products and their derivatives against coronavirus: A review of the non‐clinical and pre‐clinical data [DOI]
  13. 13 Critical assessment of the automated AutoDock as a new docking tool for virtual screening [DOI]
  14. 14 Community benchmarks for virtual screening [DOI]
  15. 15 Biological Activity and Phytochemical Analysis of Three Indonesian Medicinal Plants, Murraya koenigii, Syzygium polyanthum and Zingiber purpurea [DOI]
  16. 16 Novel paradigms for drug discovery: computational multitarget screening [DOI]
  17. 17 A Computer-Based Approach to the Rational Discovery of New Trichomonacidal Drugs by Atom-Type Linear Indices [DOI]
  18. 18 PEMBUATAN MINUMAN SERBUK INSTAN DARI BERBAGAI BAGIAN TANAMAN MENIRAN (Phyllanthus niruri) [DOI]
  19. 19 Evaluation of Ginger (Zingiber officinale Roscoe) Bioactive Compounds in Increasing the Ratio of T-cell Surface Molecules of CD3+CD4+:CD3+CD8+ In-Vitro.
  20. 20 Proteins: Structure, Function, and Bioinformatics [DOI]
  21. 21 Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches [DOI]
  22. 22 Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches [DOI]

Cited by 1

Molecular Docking Studies : Activity of Natural Compounds as SAR-CoV-2 Inhibitors in Papain-like protease (PL pro)

Nya Daniaty Malau · International Journal of Progressive Sciences and Technologies · 2023

Article metrics

Real usage data collected on this platform.

30

Page views

0

PDF downloads

4

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.